{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:53:19Z","timestamp":1760241199177,"version":"build-2065373602"},"reference-count":70,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Pituitary adenomas (PAs) are among the most common intracranial neoplasms, but despite their histologically benign nature, these tumors sometimes grow large enough to cause symptoms of mass effect such as vision loss, headaches, or hypopituitarism. When they get this large, surgery will unfortunately not be curative and, other than prolactinomas, medical options are limited, and radiation has variable efficacy in controlling growth. Understanding the genetic perturbations, such as single nucleotide polymorphisms (SNPs), that promote the formation or growth of functional and nonfunctional PAs is important because such genetic insights could improve the diagnosis and subsequent classification of PAs as well as unlock potential therapeutic targets outside contemporary standard of care. While there have been great strides in the research of SNPs as drivers of PA formation and maintenance, a comprehensive discussion of these genetic mutations has not been undertaken. In the present article, and with the goal of providing scientists and clinicians a central review, we sought to summarize the current literature on SNPs and their relationship to PA formation. Across multiple tumor types, such as nonfunctioning PAs, prolactinomas, corticotroph adenomas, somatotroph adenomas, thyrotropic adenomas, and gonadotroph adenomas, SNPs in cell surface receptors implicated in proliferation can be appreciated. Polymorphisms found in tumor suppressors and cell cycle regulators have also been identified, such as p53 SNPs in nonfunctioning PAs or cyclin D1 in prolactinomas. While the translational relevance of SNPs in the formation of PAs is still in the early stages, the use of wide-scale genomic analysis to identify patients at risk for developing PAs could yield therapeutic benefit in the future.<\/jats:p>","DOI":"10.3390\/cancers11121977","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T05:54:51Z","timestamp":1575870891000},"page":"1977","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Single-Nucleotide Polymorphisms in Pituitary Adenomas Tumorigenesis"],"prefix":"10.3390","volume":"11","author":[{"given":"Sumedh S.","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"ref_1","first-page":"319","article-title":"Pituitary adenomas: An overview","volume":"88","author":"Lake","year":"2013","journal-title":"Am. Fam. Phys."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"73","author":"Fernandez","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: A systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: A summary","volume":"134","author":"Lopez","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/jcp.2005.031187","article-title":"My approach to pathology of the pituitary gland","volume":"59","author":"Asa","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"ref_8","first-page":"1","article-title":"Growth hormone and prolactin-staining tumors causing acromegaly: A retrospective review of clinical presentations and surgical outcomes","volume":"1","author":"Rick","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: A review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11102-008-0094-6","article-title":"Transsphenoidal surgery","volume":"11","author":"Joshi","year":"2008","journal-title":"Pituitary"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11102-015-0685-y","article-title":"Nationwide shift from microscopic to endoscopic transsphenoidal pituitary surgery","volume":"19","author":"Rolston","year":"2016","journal-title":"Pituitary"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1477-7819-12-94","article-title":"Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: A meta-analysis","volume":"12","author":"Gao","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","article-title":"The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery","volume":"96","author":"Meji","year":"2002","journal-title":"J. Neurosurg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2018.02.005","article-title":"Mortality in patients with endogenous Cushing\u2019s syndrome","volume":"47","author":"Javanmard","year":"2018","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.endinu.2018.01.008","article-title":"Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus","volume":"65","author":"Bernabeu","year":"2018","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nec.2019.05.005","article-title":"Managament of pituitary adenomas invading the cavernous sinus","volume":"30","author":"Rutkowski","year":"2019","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nec.2019.05.001","article-title":"Molecular biology of pituitary adenomas","volume":"30","author":"Faltermeier","year":"2019","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ng1808","article-title":"A common variant associated with prostate cancer in European and African populations","volume":"38","author":"Amundadottir","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/bcr1842","article-title":"The role of single nucleotide polymorphisms in breast cancer metastasis","volume":"10","author":"Rae","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_20","first-page":"177","article-title":"The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma","volume":"24","year":"2017","journal-title":"Acta Med. Litu."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00701-010-0671-0","article-title":"The effect of polymorphisms in the promotor region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma","volume":"152","author":"Bayrak","year":"2010","journal-title":"Acta Neurochir."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5839528","DOI":"10.1155\/2017\/5839528","article-title":"Does MMP-9 gene polymorphism play a role in pituitary adenoma development?","volume":"2017","author":"Glebauskiene","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/BF01411124","article-title":"Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis","volume":"138","author":"Kawamoto","year":"1996","journal-title":"Acta Neurochir."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11102-018-0863-9","article-title":"Mortality in patients with non-functioning pituitary adenomas","volume":"21","author":"Tampourlou","year":"2018","journal-title":"Pituitary"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1677\/erc.1.01049","article-title":"High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy","volume":"12","author":"Pierantoni","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14791\/btrt.2016.4.1.1","article-title":"Clinical concerns about recurrence of non-functioning pituitary adenomas","volume":"4","author":"Lee","year":"2016","journal-title":"Brain Tumor. Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.13791","article-title":"Long-term follow-up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: The outcome of a conservative management policy","volume":"89","author":"Levy","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2017.02.017","article-title":"Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas","volume":"446","author":"Yagnik","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhu, B., Wang, J., Qin, L., Wang, L., Zheng, Y., Zhang, L., and Wang, W. (2018). FGFR2 gene polymorphism rs2981582 is associated with non-functioning pituitary adenomas in Chinese Han population: A case-control study. Biosci. Rep., 38.","DOI":"10.1042\/BSR20181081"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-018-03082-y","article-title":"A PHLDB1 variant associated with the nonfunctional pituitary adenoma","volume":"142","author":"Kim","year":"2019","journal-title":"J. Neurooncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/BF03345630","article-title":"Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations","volume":"31","author":"Ruggeri","year":"2008","journal-title":"J. Endocrinol. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3892\/etm.2016.3002","article-title":"SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma","volume":"11","author":"Hu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO Classification of Pituitary Tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499382","article-title":"Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours","volume":"109","author":"Trouillas","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10014-006-0196-7","article-title":"Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas","volume":"23","author":"Ikeda","year":"2006","journal-title":"Brain Tumor Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:16:1:55","article-title":"Morphologic and molecular analysis of estrogen-induced pituitary tumorigenesis in targeted disruption of transforming growth factor-beta receptor type II and\/or p27 mice","volume":"16","author":"Ikeda","year":"2001","journal-title":"Endocrine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-15-0879","article-title":"Polymorphisms in MEN1 and DRD2 genes are associated with the occurrence and characteristics of pituitary adenomas","volume":"175","author":"Peculis","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gene.2012.07.056","article-title":"Effect of cyclin D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma","volume":"509","author":"Cander","year":"2012","journal-title":"Gene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-1119(94)00562-7","article-title":"The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a review","volume":"159","author":"Schuuring","year":"1995","journal-title":"Gene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/carcin\/22.11.1801","article-title":"Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas","volume":"22","author":"Simpson","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/EJE-12-0198","article-title":"Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas","volume":"167","author":"Athanasoulia","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-014-0383-y","article-title":"Growth hormone tumor histological subtypes predict response to surgical and medical therapy","volume":"49","author":"Carlson","year":"2015","journal-title":"Endocrine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2015-3653","article-title":"Pituitary medicine from discovery to patient-focused outcomes","volume":"101","author":"Melmed","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1210\/jc.2015-3129","article-title":"Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary Adenomas","volume":"100","author":"Demir","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/endo-122-6-2764","article-title":"Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels","volume":"122","author":"Meier","year":"1988","journal-title":"Endocrinology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1210\/endo.130.1.1727697","article-title":"Pituitary adenylate cyclase-activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatotropes","volume":"130","author":"Canny","year":"1992","journal-title":"Endocrinology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1073\/pnas.92.11.5219","article-title":"Evidence for a role of pituitary ATP receptors in the regulation of pituitary function","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tateno, T., Asa, S.L., Zheng, L., Mayr, T., Ullrich, A., and Ezzat, S. (2011). The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002400"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.18632\/oncotarget.13843","article-title":"FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors","volume":"8","author":"Ezzat","year":"2017","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/gtmb.2014.0333","article-title":"Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?","volume":"19","author":"Yarman","year":"2015","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cen.12424","article-title":"Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly","volume":"81","author":"Cannavo","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ando.2018.09.007","article-title":"Association between KISS1 rs5780218 promoter polymorphism and onset of growth hormone secreting pituitary adenoma","volume":"80","author":"Amorim","year":"2019","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4614-6199-9_9","article-title":"Kisspeptin and clinical disorders","volume":"784","author":"Silveira","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Gao, M., Zhu, B., Xu, Z., Liu, S., Liu, J., Zhang, G., Gao, Y., Fan, Y., and Kang, X. (2018). Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene. BMC Med. Genet., 19.","DOI":"10.1186\/s12881-018-0698-2"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fendo.2018.00751","article-title":"Influence of the IGFBP3-202A\/C Gene Polymorphism on Clinical Features and Surgery Outcome in Acromegalic Patients","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","article-title":"Clonal origin of pituitary adenomas","volume":"71","author":"Herman","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_58","first-page":"472","article-title":"Monoclonality of corticotroph macroadenomas in Cushing\u2019s disease","volume":"75","author":"Gicquel","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","first-page":"1303","article-title":"Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing\u2019s disease","volume":"75","author":"Biller","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/joim.12975","article-title":"Current management of Cushing\u2019s disease","volume":"286","author":"Tritos","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12020-016-0990-x","article-title":"Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas","volume":"55","author":"Cassarino","year":"2017","journal-title":"Endocrine"},{"key":"ref_62","first-page":"917","article-title":"Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus","volume":"83","author":"Huizenga","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-2265.2002.01639.x","article-title":"Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours","volume":"57","author":"Antonini","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/me.2013-1412","article-title":"FGFR4 polymorphic variants modulate phenotypic features of Cushing disease","volume":"28","author":"Tateno","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1210\/jc.2010-0047","article-title":"Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing\u2019s disease outcome","volume":"95","author":"Brito","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2265.1998.00500.x","article-title":"The GnRH receptor gene is preferentially expressed in functioning gonadotroph adenomas and displays a Mae III polymorphism site","volume":"49","author":"Kottler","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11102-018-0921-3","article-title":"Thyrotropin-secreting pituitary adenomas: A systematic review and meta-analysis of postoperative outcomes and management","volume":"22","author":"Cossu","year":"2019","journal-title":"Pituitary"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: Epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/jc.2016-2261","article-title":"Whole-exome sequencing study of thyrotropin-secreting pituitary adenomas","volume":"102","author":"Sapkota","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/BF03347536","article-title":"Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas","volume":"27","author":"Filopanti","year":"2004","journal-title":"J. Endocrinol. Investig."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1977\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:40:35Z","timestamp":1760190035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cancers11121977"],"URL":"https:\/\/doi.org\/10.3390\/cancers11121977","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2019,12,9]]}}}